Can Multiple Myeloma Be Cured? CAR T & New Breakthroughs Explained: Myeloma QA Replay

Can You Get CAR T If You Live Alone? This and Other Myeloma Treatment Questions Answered | REPLAY

Just Diagnosed With Multiple Myeloma? Ask Your Doctor These 3 Questions (In 60 Seconds)

Does Myeloma Come Back More Aggressively? MGUS, High-Risk & Dex Questions Answered

Are Clinical Trials Safe for Multiple Myeloma? (In Less Than a Minute)

Early Signs of Multiple Myeloma: Symptoms, MGUS, and When to See a Doctor

Movement as Medicine: Exercise Tips for Multiple Myeloma Patients & Care Partners

80% Still in Remission? MajesTEC-3 Myeloma Breakthrough Explained & More From ASH 2025

Can CAR T-cells Be Made Inside the Body? Major Multiple Myeloma Breakthroughs from ASH 2025

What Is Multiple Myeloma? A Simple Guide for Newly Diagnosed

Kilimanjaro Study: Etentamig Plus Pomalidomide-Dex Shows Robust Efficacy in Relapsed Myeloma

CARTITUDE-4: Exceptional Long-Term Outcomes with Cilta-cel in Standard-Risk Relapsed Myeloma

Talquetamab + Teclistamab Show Promising Efficacy in Relapsed/Refractory Multiple Myeloma with EMD ​

Anitocabtagene Autoleucel iMMagine-1 Trial: Exceptional Safety and Durability in Relapsed Myeloma

Why Myeloma Treatments Stop Working, What Remission Really Means & More | Myeloma Questions Answered

Meet the New IMF President & CEO: Heather Cooper Ortner Answers Your Questions: Myeloma Community QA

ELREXFIO (elranatamab) for Multiple Myeloma: Patient Story + Doctor Explains

MajesTEC-3: Teclistamab-Daratumumab Establishes New Standard of Care in Early Relapsed Myeloma

KLN-1010 In Vivo CAR-T Therapy: Revolutionary Off-the-Shelf Treatment for Multiple Myeloma

Top Myeloma Research Presented at ASH 2025

Top 10 Multiple Myeloma Breakthroughs from ASH 2025 | CAR-T & Bispecific Antibodies Explained

Cilta-cel Safety: Understanding Risk Factors for Delayed Side Effects

IFM2021-01 TecLille Trial: Teclistamab-Daratumumab Combination in Elderly NDMM Patients

IMWG Conference Series ASH 2025: Making Sense of Treatment

Myeloma Pain Explained by a Myeloma Expert | Myeloma in a Minute

Watch the Facebook Live Replay from the 2025 American Society of Hematology (ASH) Meeting

Can We Prevent Multiple Myeloma? | IMWG Dr. Shaji Kumar (Mayo Clinic) on Risk, MGUS, Early Treatment

Will Myeloma Ever Be Curable? Answering Real Multiple Myeloma Patient Questions

You’re Not Alone: Join a Myeloma Support Group Today

What’s the ‘Right’ Answer? – Controversies in Myeloma

Multiple Myeloma Documentary 2024: Iceland Cycling Expedition for Research & Hope

Your Myeloma Questions Answered: PET Scans, Side Effects, and New Treatment Options

The International Myeloma Foundation | 35 Years

25 Years With Multiple Myeloma: Michael & Robin Tuohy’s Journey of Hope and Resilience

High-Risk Smoldering Myeloma & New Frontline Treatment: What Patients Need to Know | IMS Part 2 of 2

IMS Highlights: Frontline Wins, High-Risk Insights, and What’s Next in Myeloma | Part 1 of 2

Kathy’s Myeloma Journey | Stem Cell Transplants, Relapse, and Clinical Trials

Pedal to Change Lives. The 2026 Iceland Cycling Expedition to End Multiple Myeloma

Alma’s Myeloma Journey | Clinical Trials, Advocacy, and Thriving After Diagnosis

Living Well with Myeloma: Infection Prevention and Management

Terrence & Toni’s Myeloma Journey | Love, Advocacy and 10 Years of Hope

Replay the Facebook Live from 9/30 | Beth Faiman Discusses Frontline CAR T, Cevostamab, Trispecifics

Replay the Facebook Live from 9/8 | Dr. Joseph Mikhael Answers CAR T, MRD Negativity & Myeloma

Joan’s Myeloma Journey | Clinical Trials, Family Support, and Living with Myeloma

Diagnosed with Myeloma at 34: Thomas Shares His Stem Cell Transplant & Clinical Trial Experience

Is CAR T-Cell Therapy the Closest Thing to a Myeloma Cure? | CAR T-Cell Therapy Explained

CAR T-cell Therapy & MRD Negativity in Myeloma: What Patients Need to Know

Blood Cells and Multiple Myeloma: What You Need to Know | Understanding Anemia & Other Effects

Will We Ever Screen for Multiple Myeloma? | Early Detection of Myeloma

Bispecific Antibodies Explained: How Bispecific Antibodies Use the Immune System

Types of Multiple Myeloma & Why They Matter for Patients | #KnowMyeloma

Who’s Most Likely to Get Multiple Myeloma? | Risk by Age, Gender & Race Explained

How Common Is Multiple Myeloma? The Truth About This Lesser Known Blood Cancer

Controversies in Myeloma: Smoldering, Transplant vs CAR T, Dex, Maintenance & Bispecific Sequencing

Closing the Gap in Myeloma: Health Disparities, Delayed Diagnosis & the IMF M-Power Program

Managing Myeloma Symptoms: Infection Prevention, Bone Health, Kidney Care & Side Effect Management

U.S. Policy Updates 2025: Medicare Cap, Drug Parity, Telehealth, and How Patients Can Get Involved

The Future of Myeloma: Screening, Smoldering Strategies, CAR T vs Transplant, and MRD-Guided Care

A Day in the Life of Mindy Fast & Mike Kastner | Navigating the Multiple Myeloma Journey

Understanding Clinical Trials in Myeloma: Phases, Benefits, Risks & Patient Access